Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.

Shah PK, Narendran V, Tawansy KA, Raghuram A, Narendran K.

Indian J Ophthalmol. 2007 Jan-Feb;55(1):75-6.

2.

Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity.

Sangtam T, Vinekar A, Maheshwar B, Dogra MR, Eong KG.

Indian J Ophthalmol. 2007 Jul-Aug;55(4):317; author reply 317-8. No abstract available.

3.

Antivascular endothelial growth factor for retinopathy of prematurity.

Mintz-Hittner HA, Best LM.

Curr Opin Pediatr. 2009 Apr;21(2):182-7. doi: 10.1097/MOP.0b013e32832925f9. Review.

PMID:
19300261
4.

Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

Chung EJ, Kim JH, Ahn HS, Koh HJ.

Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1727-30.

PMID:
17690897
5.

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group..

N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374.

6.

Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).

Wutthiworawong B, Thitiratsanont U, Saovaprut C, Subhangkasen I, Geyuraphun B, Ampornprut A, Phumongkutchai J, Tephusdinnaayuthaya S.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S15-21.

PMID:
22043749
7.

Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).

Dorta P, Kychenthal A.

Retina. 2010 Apr;30(4 Suppl):S24-31. doi: 10.1097/IAE.0b013e3181ca1457.

PMID:
20224475
8.

Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.

Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K.

Am J Ophthalmol. 2010 Jun;149(6):964-972.e1. doi: 10.1016/j.ajo.2010.01.008.

PMID:
20381786
9.

Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report.

Sun HJ, Choi KS, Lee SJ.

Jpn J Ophthalmol. 2012 Sep;56(5):476-80. doi: 10.1007/s10384-012-0141-8.

PMID:
22843138
10.

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE, Prieto I, Pires G, van Velze R, Valido A, Machado Mdo C.

Ophthalmic Surg Lasers Imaging. 2007 May-Jun;38(3):233-7.

PMID:
17552391
11.

Bevacizumab for retinopathy of prematurity.

Reynolds JD.

N Engl J Med. 2011 Feb 17;364(7):677-8. doi: 10.1056/NEJMe1100248. No abstract available.

PMID:
21323546
12.

Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.

Axer-Siegel R, Snir M, Ron Y, Friling R, Sirota L, Weinberger D.

Retina. 2011 Jul-Aug;31(7):1239-47. doi: 10.1097/IAE.0b013e31820d4000.

PMID:
21555969
13.

Comment on "Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity".

Er H.

Retina. 2009 Oct;29(9):1380; author reply 1379-80. doi: 10.1097/IAE.0b013e3181b8620b. No abstract available.

PMID:
19934833
14.

Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity.

Atchaneeyasakul LO, Trinavarat A.

J Perinatol. 2010 Jul;30(7):497-9. doi: 10.1038/jp.2009.166.

PMID:
20585321
15.

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU.

Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. No abstract available.

16.

Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.

Nazari H, Modarres M, Parvaresh MM, Ghasemi Falavarjani K.

Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1713-8. doi: 10.1007/s00417-010-1430-x.

PMID:
20582706
17.

Anterior segment ischemia following laser therapy for threshold retinopathy of prematurity.

Gaitan JR, Berrocal AM, Murray TG, Hess D, Johnson RA, Mavrofrides EC.

Retina. 2008 Mar;28(3 Suppl):S55-7. doi: 10.1097/IAE.0b013e318159ec39. Erratum in: Retina. 2009 Jan;29(1):127.

PMID:
18317346
19.

Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.

dell'Omo R, Kulkarni A, Franks WA.

Acta Ophthalmol. 2008 Sep;86(6):698-700. No abstract available.

20.

Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.

Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D, Johnson RA, Puliafito CA.

Retina. 2008 Mar;28(3 Suppl):S13-8. doi: 10.1097/IAE.0b013e3181644ad2. Erratum in: Retina. 2009 Jan;29(1):127.

PMID:
18317338
Items per page

Supplemental Content

Support Center